Logo image of PTP.DE

PENTIXAPHARM HOLDING AG (PTP.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:PTP - DE000A40AEG0 - Common Stock

2 EUR
+0.03 (+1.52%)
Last: 1/23/2026, 7:00:00 PM
Fundamental Rating

2

PTP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for PTP as it has an excellent financial health rating, but there are worries on the profitability. PTP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year PTP has reported negative net income.
  • In the past year PTP has reported a negative cash flow from operations.
PTP.DE Yearly Net Income VS EBIT VS OCF VS FCFPTP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2024 0 5M -5M -10M

1.2 Ratios

  • PTP has a Return On Assets of -59.32%. This is amonst the worse of the industry: PTP underperforms 86.57% of its industry peers.
  • Looking at the Return On Equity, with a value of -69.40%, PTP is doing worse than 77.61% of the companies in the same industry.
Industry RankSector Rank
ROA -59.32%
ROE -69.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PTP.DE Yearly ROA, ROE, ROICPTP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2024 0 10 -10 -20

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PTP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PTP.DE Yearly Profit, Operating, Gross MarginsPTP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2024 0 100 -100

8

2. Health

2.1 Basic Checks

  • PTP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PTP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTP.DE Yearly Shares OutstandingPTP.DE Yearly Shares OutstandingYearly Shares Outstanding 2024 5M 10M 15M 20M
PTP.DE Yearly Total Debt VS Total AssetsPTP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.18 indicates that PTP is not in any danger for bankruptcy at the moment.
  • PTP's Altman-Z score of 3.18 is fine compared to the rest of the industry. PTP outperforms 65.67% of its industry peers.
  • There is no outstanding debt for PTP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.18
ROIC/WACCN/A
WACC7.45%
PTP.DE Yearly LT Debt VS Equity VS FCFPTP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 3.48 indicates that PTP has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.48, PTP belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
  • A Quick Ratio of 3.48 indicates that PTP has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.48, PTP belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.48
Quick Ratio 3.48
PTP.DE Yearly Current Assets VS Current LiabilitesPTP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2024 10M 20M 30M

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14325%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PTP.DE Yearly Revenue VS EstimatesPTP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2M 4M 6M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PTP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PTP.DE Price Earnings VS Forward Price EarningsPTP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PTP.DE Per share dataPTP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • PTP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PENTIXAPHARM HOLDING AG / PTP.DE FAQ

What is the ChartMill fundamental rating of PENTIXAPHARM HOLDING AG (PTP.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PTP.DE.


What is the valuation status of PENTIXAPHARM HOLDING AG (PTP.DE) stock?

ChartMill assigns a valuation rating of 0 / 10 to PENTIXAPHARM HOLDING AG (PTP.DE). This can be considered as Overvalued.


How profitable is PENTIXAPHARM HOLDING AG (PTP.DE) stock?

PENTIXAPHARM HOLDING AG (PTP.DE) has a profitability rating of 0 / 10.


What is the financial health of PENTIXAPHARM HOLDING AG (PTP.DE) stock?

The financial health rating of PENTIXAPHARM HOLDING AG (PTP.DE) is 8 / 10.